TY - JOUR
T1 - Treatment of racemose neurocysticercosis
AU - McClugage, Samuel
AU - Lee, Rachael
AU - Camins, Bernard
AU - Mercado-Acosta, Juan
AU - Rodriguez, Martin
AU - Riley, Kristen
N1 - Publisher Copyright:
© 2017 Surgical Neurology International | Published by Wolters Kluwer - Medknow.
PY - 2017
Y1 - 2017
N2 - Background: Neurocysticercosis (NCC) is a common parasitic infection of the central nervous system, caused by the tapeworm Taenia solium. It is endemic to certain parts of the world, including Central America, South America, Asia, and Africa. The racemose form, characterized by extraparenchymal location, increased morbidity and mortality, and large loculated cystic lesions, is rarely seen in industrialized countries, such as the United States. The management of racemose neurocysticercosis (RNCC) differs from that of the typical parenchymal variant. The ideal course of treatment is debated by experts, but typically includes either surgical intervention with subsequent medical therapy or medical therapy alone. Case Description: We present the case of a 34-year-old male diagnosed with RNCC and treated successfully with surgical cyst drainage, resection, and subsequent medical therapy. Conclusion: Currently, no standardized evidence-based protocol exists that dictate appropriate treatment for extraparenchymal or racemose NCC. We present a case of RNCC treated successfully with surgical and medical intervention. Further research encompassing well-designed clinical trials is necessary to delineate appropriate and standardized protocols for treatment of this disease.
AB - Background: Neurocysticercosis (NCC) is a common parasitic infection of the central nervous system, caused by the tapeworm Taenia solium. It is endemic to certain parts of the world, including Central America, South America, Asia, and Africa. The racemose form, characterized by extraparenchymal location, increased morbidity and mortality, and large loculated cystic lesions, is rarely seen in industrialized countries, such as the United States. The management of racemose neurocysticercosis (RNCC) differs from that of the typical parenchymal variant. The ideal course of treatment is debated by experts, but typically includes either surgical intervention with subsequent medical therapy or medical therapy alone. Case Description: We present the case of a 34-year-old male diagnosed with RNCC and treated successfully with surgical cyst drainage, resection, and subsequent medical therapy. Conclusion: Currently, no standardized evidence-based protocol exists that dictate appropriate treatment for extraparenchymal or racemose NCC. We present a case of RNCC treated successfully with surgical and medical intervention. Further research encompassing well-designed clinical trials is necessary to delineate appropriate and standardized protocols for treatment of this disease.
KW - Cyst rupture
KW - Taenia solium
KW - medication
KW - neurocysticercosis
KW - racemose
KW - surgery
KW - treatment
UR - http://www.scopus.com/inward/record.url?scp=85043573558&partnerID=8YFLogxK
U2 - 10.4103/sni.sni_157_17
DO - 10.4103/sni.sni_157_17
M3 - Article
AN - SCOPUS:85043573558
SN - 2152-7806
VL - 8
JO - Surgical Neurology International
JF - Surgical Neurology International
IS - 1
M1 - 168
ER -